Disease Risk Calculator
Cartel: A cartel is a formal (explicit) agreement among competing firms. [An agreement that has the effect of 'fixing' the market. Cartels are illegal in most countries.] (Wikipedia)
Last week I (editor Steve) highlighted some concerns about the way the UK's fledgling 3millionlives (3ML) campaign is shaping up, particularly in the matter of the MOU the Working Group expects companies to sign and the initial £10,000 cost of entry - with an uncapped commitment after that. I asked for comments from people who could make a positive case for the initiative. The comments so far - thank you - have been lukewarm. If you have not yet read the earlier item, read it first.
I have had private comments from some companies who were understandably reluctant to comment publicly. In summary, the concerns they expressed were... [Read more...]
And Medilink's press release on 3ML does nothing to dispel the misgivings: "Medilink UK's Chairman Tony Davis added: 'As well as the millions of lives that will be improved through this initiative, there are many Medilink members who stand to benefit hugely from the ‘3millionlives' campaign. As growing SMEs, they really want the doors to the NHS to be opened, and for healthcare professionals to be actively seeking telehealth and telecare solutions. By joining together, and by working with the Department of Health, they will be in the ideal position to take commercial advantage of the opportunities as they become available.'"
The Financial Times reports that a wirelessly controlled implant delivering daily doses of drugs, developed by MIT spinoff MicroChips, has succeeded in its first clinical trial in Denmark. The results were announced at the start of the American Association for the Advancement of Science annual meeting on Thursday. The drug delivery times are either pre-programmed into the chip, or it is activated wirelessly by the doctor to release the dose. 'Pharmacy on a chip' passes test